Comparison of the E-test method with an automated bacterial identification and antimicrobial susceptibility detection system for screening extended-spectrum β-lactamase producers

Scandinavian Journal of Infectious Diseases

Volumn 35, Issue 10, 2003, Pages 700-703

  Özakin, Cuneyt ^a   Sinirtaş, Melda ^a   Sevgican, Emine ^a   Kazak, Esra ^a   Gedikoglu, Suna ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CLAVULANIC ACID;

ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOANALYSIS; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; ENZYME SYNTHESIS; ESCHERICHIA COLI; EUROPE; INTERMETHOD COMPARISON; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SCREENING TEST; TURKEY (REPUBLIC); UNITED STATES;

AUTOMATION; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CEPHALOSPORINS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; KLEBSIELLA; KLEBSIELLA INFECTIONS; MICROBIAL SENSITIVITY TESTS;

EID: 0242351602     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540310016006     Document Type: Article

References (22)

1. Finch RG. Antibiotic resistance. J Antimicrob Chemother 1998; 42: 125-8.
2. Quinn JP. Clinical significance of extended spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis 1994; 13(Suppl 1): 39.
3. Archibald L, Phillips L, Monnet D, McGowan Jr JE, Tenover F, Gaynes R. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 1997; 24: 211-5.
4. Andrasevic AT, Tambic T, Kalenic S, Jankovic V, Working Group of the Croatian Committee for Antibiotic Resistance Surveillance. Surveillance for antimicrobial resistance in Croatia. Emerg Infect Dis 2002; 8: 14-8.
5. Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, Weinstein RA. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999; 281: 517-23.
6. Bush K. Is it important to identify extended-spectrum β-lactamase-producing isolates? Eur J Clin Microbiol Infect Dis 1996; 15: 361-4.
7. Fierer J, Guiney D. Extended-spectrum β-lactamases: a plague of plasmids. JAMA 1999; 281: 563-4.
8. Einhorn AE, Neuhauser MM, Bearden DT, Quinn JP, Pendland SL. Extended-spectrum beta-lactamases: frequency, risk factors, and outcomes. Pharmacotherapy 2002; 22: 14-20.
9. Leblebicioglu H, Gunaydin M, Esen S, Tuncer I, Findik D, Ural O, et al., Study Group. Surveillance of antimicrobial resistance in Gram-negative isolates for intensive care units in Turkey: analysis of data from the last 5 years. J Chemother 2002; 14: 140-6.
10. Gross R, Hoerling J, Eigner U, Fahr AM. The importance of extended-spectrum β-lactamases (ESBL) screening tests in rapid automated antimicrobial susceptibility testing (AST). 41st Annual ICAAC 2001, Chicago, IL; presentation no. 184.
11. Sceptor Numerical Identification System, Enterobacteriaceae and Miscellaneous Gram-Negative Bacteria, Instructions for Use of The Sceptor Taxonomy Guide and Sceptor MIC/ID System. Towson, USA; 1990.
12. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing M100-S10. Wayne, PA: NCCLS; 2000.
13. Iftikhar A, Abdus S. Extended spectrum beta-lactamases and bacterial resistance. Pak J Med Sci 2002; 18: 151.
14. Katsanis GB, Spargo J, Ferraro MJ, Sutton L, Jacoby GA. Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended spectrum beta-lactamases. J Clin Microbiol 1994; 32: 691.
15. Palasubramaniam S, Parasakhi N. Comparison of three different methods for the presumptive detection of ESBL production in ceftazidime-resistant strains of Klebsiella pneumoniae. Malays J Pathol 2001; 23: 73-8.
16. European Antimicrobial Resistance Surveillance System, EARSS Annual Report 2001 (On-going surveillance of S. pneumoniae, S. aureus, E. coli, E. faecalis/E. faecium). Bilthoven, The Netherlands; July 2002.
17. Bell JM, Turnidge JD, Gales AC, Pfaller MA, Jones RN, SENTRY APAC Study Group. Prevalence of extended spectrum β-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99). Diag Microbiol Infect Dis 2002; 42: 193-8.
18. Jones RN, Pfaller MA, Doern GV, Erwin ME, Hollis RJ. Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group. Diagn Microbiol Infect Dis 1998; 30: 215-28.
19. Garcia-Rodriguez JA, Jones RN, MYSTIC Programme Study Group. Antimicrobial resistance in Gram-negative isolates from European intensive care units: data from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) programme. J Chemother 2002; 14: 25-32.
20. Aktas E, Yigit N, Yazgi H, Ayyildiz A. Detection of anti-microbial resistance and extended-spectrum beta-lactamase production in Klebsiella pneumoniae strains from infected neonates. J Int Med Res 2002; 30: 445-8.
21. Ozkan C, Oldacay M, Erdem G. Frequency of extended spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae strains isolated from nosocomial infections. ANKEM Dergisi 2002; 16: 65-8.
22. Caglar K, Akca G, Onder E, Karakus R. Çesitli Enterobacteriaceae Izolatlarinda Genis Spektrumlu Beta-Laktamaz Üretme Sikligi. X. Türk Klinik Mikrobiyoloji ve Infeksiyon Hastaliklari Kongresi, 15-19 Eylül 2001, Adana; Türkiye